Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Affiliations

• ¹ Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece. kosliapis@hotmail.com.
• ² Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece.
• ³ Department of Clinical Hematology, Georgios Gennimatas Hospital, Athens, Greece.
• ⁴ Second Department of Internal Medicine, Attikon University General Hospital, Athens, Greece.
• ⁵ First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
• ⁶ Greece Department of Internal Medicine, University Hospital of Patras, Rio, Greece.
• ⁷ Department of Hematology, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
• ⁸ Department of Hematology, University Hospital of Ioannina, Ioannina, Greece.
• ⁹ Department of Hematology, University Hospital of Larissa, Larissa, Greece.
• ¹⁰ Department of Hematology, University General Hospital of Heraklion, Voutes, Heraklion, Greece.
• ¹¹ Department of Hematology, Metaxa Oncology Hospital, Piraeus, Greece.
• ¹² Department of Hematology, Aghios Andreas General Hospital, Patras, Greece.
• ¹³ First Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
• ¹⁴ Department of Hematology, Sotiria General Hospital, Athens, Greece.
• ¹⁵ Department of Hematology, AHEPA University Hospital, Thessaloniki, Greece.
• ¹⁶ Department of Hematology and Stem cell Transplantation, Georgios Papanicolaou General Hospital, Thessaloniki, Greece.
• ¹⁷ Second Department of Internal Medicine, National and Kapodistrian University of Athens, Hippokratio General Hospital, Athens, Greece.
• ¹⁸ Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece.
• ¹⁹ Department of Hematology and Thalassemia, Kalamata General Hospital, Kalamata, Greece.